← Open Payments lookup

JAMIE BOUCHARD: Open Payments

NPI 1740661917 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$770 in 39 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $939 · 2025 $770

Food & beverage: $619Education: $151
CompanyPaymentsAmount
ABBVIE INC.11$169
Teva Pharmaceuticals USA, Inc.3$147
Alkermes, Inc.12$147
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$82
Tempus AI, Inc2$57
Neurocrine BioSciences, Inc.2$49
Collegium Pharmaceutical, Inc.2$42
Supernus Pharmaceuticals, Inc.2$34
E.R. Squibb & Sons, L.L.C.1$22
Lundbeck LLC1$22

Products named: VRAYLAR, ARISTADA, CAPLYTA, LYBALVI, TEMPUS PIXEL, INGREZZA, AUSTEDO XR, Jornay PM.

Industry payments across TX — which companies pay providers there.